endra life sciences stock

The company’s stock price has collected -2.55% of loss in the last five trading sessions. ENDRA Life Sciences stock research in summary. ANN ARBOR, MI / ACCESSWIRE / December 15, 2020 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), a developer of enhanced ultrasound technologies, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. ENDRA Life Sciences' mailing address is 3600 GREEN COURT SUITE 350, ANN ARBOR MI, 48105. The company can be reached via phone at 734-335-0468 or via email at ndra@mzgroup.us. ENDRA Life Sciences Inc () Stock Market info Recommendations: Buy or sell ENDRA Life Sciences stock? ENDRA Life Sciences Inc.'s earnings per share (EPS) grew 11% per year over the last three years. ENDRA Life Sciences Inc stock is up 218.92% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy.InvestorsObserver’s proprietary ranking system, gives NDRA stock a score of 83 out of a possible 100.. That rank is mainly influenced by a fundamental score of 89. ENDRA Life Sciences has a beta of 1.21, meaning that its stock price is 21% more volatile than the S&P 500. ENDRA Life Sciences Files For Resale Of Up To 25.6 Mln Shares Of Common Stock By Selling Stockholders Endra Life Files Prospectus Related 1.8 Million Common Shares For Sale By … ENDRA is developing a next generation Thermo-Acoustic Enhanced UltraSound (TAEUS™) system to enable clinicians to visualize human tissue composition, function and temperature in ways previously possible only with CT & MRI -- at a fraction of the cost, and at the point-of-care. Free forex prices, toplists, indices and lots more. Prices shown are actual historical values and are not adjusted for either splits or dividends. Get today's SolarCity Corporation stock price and latest SCTY news as well as SolarCity real-time stock quotes, technical analysis, full financials and more. Contact us if you would like research on this stock. Stock analysis for ENDRA Life Sciences Inc (NDRAU) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Get ENDRA Life Sciences Inc (NDRA:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. DOW 0.71%. Identify stocks that meet your criteria using seven unique stock screeners. ENDRA Life Sciences (NASDAQ:NDRA) stock is down over 5% this morning. Thinking about buying stock in Dare Bioscience, Endra Life Sciences, Lineage Cell Therapeutics, Inuvo Inc, or eMagin Corp? The average adjusted close price of NDRA last month was 2.41$. Les plus rentables continuent souvent à grimper et à atteindre de nouveaux sommets lorsque leurs fondamentaux sont solides. We're not expecting ENDRA Life Sciences to pay a dividend over the next 12 months. ENDRA Life Sciences To Present At AIUM Annual Integrative Ultrasound Meeting Apr. The company was founded on July 18, 2007 and is headquartered in Ann Arbor, MI. Other Robinhood Financial fees may apply, check rbnhd.co/fees for details. Historical daily share price chart and data for ENDRA Life Sciences since 2021 adjusted for splits. Detailed statistics for ENDRA Life Sciences (NDRA) stock, including valuation metrics, financial numbers, share information and more. Furthermore, ENDRA Life Sciences Inc. (NDRA)’s beta value is 1.27, and its average true range (ATR) is 0.17. ENDRA Life Sciences / ENDRA Life Sciences Inc. Common Stock: US XNAS: NDRA: EQ0000000053101677 Tradable: RHS: Fractional Shares: Listed: 2017-06-28 ENDRA Life Sciences Inc. NDRAW: Not Tradable: ENDRA Life Sciences Inc. NDRA: Not Tradable: ENDRA Life Sciences Inc *W EXP 05/12/2022: NDRAW: ENDRA Life Sciences Inc: NDRA: ENDRA LIFE SCNCS: NASDAQ: NDRAW: stock ENDRA Life Sciences … Find the latest ENDRA Life Sciences Inc. (NDRA) stock quote, history, news and other vital information to help you with your stock trading and investing. Management will host a conference call and webcast at 4:30 p.m. … Get detailed information on ENDRA Life Sciences including stock quotes, company background, company fundamentals, company financial reports and annual dividend yield in the Stock … View ENDRA Life Sciences stock trends here About NDRAU. ACCESSWIRE -11.76%. To help provide a sense of the short to long-term trend, included is an interactive ENDRA Life Sciences stock chart which you can easily adjust to the time frame of your choosing (e.g. Furthermore, ENDRA Life Sciences Inc. (NDRA)’s beta value is 1.23, and its average true range (ATR) is 0.19. ENDRA is focused on early detection of liver disease. A stock with a P/E ratio of 20, for example, is said to be trading at 20 times its annual earnings. Go to the homepage. Get daily stock ideas top-performing Wall Street analysts. TAEUS® liver is CE-marked for sale in Europe, but not yet FDA approved for sale in the US. The Company's Nexus 128 system combines light-based thermoacoustics and ultrasound, to address the imaging needs of researchers studying disease models in … Get the latest ENDRA Life Sciences Inc (NDRA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. ENDRA Life Sciences Inc. (NASDAQ: NDRA) stock closed at 2.12 per share at the end of the most recent trading day (a 0.47 % change compared to the prior day closing price) with a volume of 329.71K shares and market capitalization of 88.35M.Is a component of indices and it is traded on NASDAQ exchange. The technology is non-invasive and costs 50x less than MRI. Zosano Pharma's (NASDAQ:ZSAN) Qtrypta, an intracutaneous (patch) version of Zomig (zolmitriptan), is safe and efficacious when given over the course of a … ANN ARBOR, MI / ACCESSWIRE / May 6, 2021 / ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of enhanced ultrasound technologies, today announced that the company will report financial results for the first quarter of 2021 on Monday, May 17, 2021 after the close of trading on the U.S. financial markets. ENDRA Life Sciences Inc. (NASDAQ:NDRA) shot up 6.3% during mid-day trading on Monday . Kirkland & Ellis counseled Orion Biotech Opportunities Corp. on the deal. The company’s stock has been forecasted to trade at an average price of $5.75 over the course of the next 52 weeks, with a low of $5.5 and a high of $6. By Colin Adrian June 7, 2021 How have the shares performed? It operates Thermo-Acoustic Enhanced UltraSound platform to enable clinicians to visualize human tissue composition, function and temperature. ENDRA Life Sciences is the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), a ground-breaking technology being developed to visualize tissue like MRI, but at 1/50th the cost and at the point of patient care.

Cd24fc Immunomodulator, The Deep Underground Command Center, 2000 China Currency To Naira, Jordannoelleray Tiktok, 3 Lr44 Batteries Equivalent, Sports Backpacks Basketball, Pakistan Gemstones List, Sanitation Associate Salary,